Johnson & Johnson (JNJ): FY25 Q1 earnings call, Apr 15, 2025
No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Apr 15, 2025 earnings call (FY25 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
22 matches for “Tariff”; 5 quoted, at least 25 words apart.
…improvement takes into consideration the dilution from the IntraCellular transaction as well as what we know today about the impact of tariffs on our business.
…guidance. Despite $0.25 dilution from the IntraCellular acquisition, including the impact of tariffs, based on what is in place today, we are pleased to be…
…congrats on a nice quarter. Joe, you talked about $400 million in tariffs in the 2025 guidance or about fourteen cents by our math. What…
…what's included in the $400 million, and again, that is primarily MedTech tariffs at this point. It's based on the programs that have been announced…
…to us a very small degree some of the steel and aluminum tariffs that impact some of our products. It includes the China tariffs as…
Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-04-15:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-04-15:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP